# FDA Inspection 1298296 - Mitsubishi Tanabe Pharma Development America, Inc. - September 18, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/mitsubishi-tanabe-pharma-development-america-inc/dceb2a25-e1ea-4e5b-a250-2f0f9fccf476
Source feed: FDA_Inspections

> FDA Inspection 1298296 for Mitsubishi Tanabe Pharma Development America, Inc. on September 18, 2025. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1298296
- Company Name: Mitsubishi Tanabe Pharma Development America, Inc.
- Inspection Date: 2025-09-18
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1298296 - 2025-09-18](https://www.globalkeysolutions.net/records/fda_inspections/mitsubishi-tanabe-pharma-development-america-inc/966fdd86-5f4d-4564-b692-4041fbe72ffd)
- [FDA Inspection 1155136 - 2021-10-15](https://www.globalkeysolutions.net/records/fda_inspections/mitsubishi-tanabe-pharma-development-america-inc/f7044b8b-5d0a-4038-b5b4-93419bd38f76)
- [FDA Inspection 857641 - 2013-12-04](https://www.globalkeysolutions.net/records/fda_inspections/mitsubishi-tanabe-pharma-development-america-inc/24eb30a9-ccc6-44e7-bcfa-9e1a8da6556c)

Company: https://www.globalkeysolutions.net/companies/mitsubishi-tanabe-pharma-development-america-inc/f5e77e46-b625-4cdd-a44a-ecd7583b6baa

Office: https://www.globalkeysolutions.net/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248